| node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
| ADIPOQ | ADIPOR2 | ENSSSCP00000046998 | ENSSSCP00000000805 | C1q domain-containing protein. | Adiponectin receptor protein 2 isoform X1. | 0.999 |
| ADIPOQ | APLN | ENSSSCP00000046998 | ENSSSCP00000071811 | C1q domain-containing protein. | Apelin. | 0.565 |
| ADIPOQ | CFD | ENSSSCP00000046998 | ENSSSCP00000014267 | C1q domain-containing protein. | Complement factor D; Factor D cleaves factor B when the latter is complexed with factor C3b, activating the C3bbb complex, which then becomes the C3 convertase of the alternate pathway. Its function is homologous to that of C1s in the classical pathway (By similarity). | 0.806 |
| ADIPOQ | IL6 | ENSSSCP00000046998 | ENSSSCP00000023819 | C1q domain-containing protein. | Interleukin-6; Cytokine with a wide variety of biological functions. It is a potent inducer of the acute phase response. Plays an essential role in the final differentiation of B-cells into Ig-secreting cells Involved in lymphocyte and monocyte differentiation. Acts on B-cells, T-cells, hepatocytes, hematopoietic progenitor cells and cells of the CNS. Required for the generation of T(H)17 cells. Also acts as a myokine. It is discharged into the bloodstream after muscle contraction and acts to increase the breakdown of fats and to improve insulin resistance. It induces myeloma and plasm [...] | 0.803 |
| ADIPOQ | INS | ENSSSCP00000046998 | ENSSSCP00000044635 | C1q domain-containing protein. | Insulin A chain; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.915 |
| ADIPOQ | LEP | ENSSSCP00000046998 | ENSSSCP00000056831 | C1q domain-containing protein. | Leptin; Key player in the regulation of energy balance and body weight control. Once released into the circulation, has central and peripheral effects by binding LEPR, found in many tissues, which results in the activation of several major signaling pathways (By similarity). In the hypothalamus, acts as an appetite-regulating factor that induces a decrease in food intake and an increase in energy consumption by inducing anorexinogenic factors and suppressing orexigenic neuropeptides, also regulates bone mass and secretion of hypothalamo-pituitary-adrenal hormones. In the periphery, inc [...] | 0.971 |
| ADIPOQ | NAMPT | ENSSSCP00000046998 | ENSSSCP00000043109 | C1q domain-containing protein. | Nicotinamide phosphoribosyltransferase; Catalyzes the condensation of nicotinamide with 5- phosphoribosyl-1-pyrophosphate to yield nicotinamide mononucleotide, an intermediate in the biosynthesis of NAD. It is the rate limiting component in the mammalian NAD biosynthesis pathway. The secreted form behaves both as a cytokine with immunomodulating properties and an adipokine with anti-diabetic properties, it has no enzymatic activity, partly because of lack of activation by ATP, which has a low level in extracellular space and plasma. Plays a role in the modulation of circadian clock fun [...] | 0.807 |
| ADIPOQ | RETNLB | ENSSSCP00000046998 | ENSSSCP00000012720 | C1q domain-containing protein. | Resistin-like beta protein. | 0.904 |
| ADIPOQ | SERPINE1 | ENSSSCP00000046998 | ENSSSCP00000026436 | C1q domain-containing protein. | Plasminogen activator inhibitor 1; Serine protease inhibitor. Inhibits TMPRSS7. Is a primary inhibitor of tissue-type plasminogen activator (PLAT) and urokinase- type plasminogen activator (PLAU). As PLAT inhibitor, it is required for fibrinolysis down-regulation and is responsible for the controlled degradation of blood clots. As PLAU inhibitor, it is involved in the regulation of cell adhesion and spreading. Acts as a regulator of cell migration, independently of its role as protease inhibitor. It is required for stimulation of keratinocyte migration during cutaneous injury repair. I [...] | 0.642 |
| ADIPOQ | TLR4 | ENSSSCP00000046998 | ENSSSCP00000060828 | C1q domain-containing protein. | Toll-like receptor 4; Cooperates with LY96 and CD14 to mediate the innate immune response to bacterial lipopolysaccharide (LPS). Acts via MYD88, TIRAP and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response. Also involved in LPS-independent inflammatory responses triggered by free fatty acids, such as palmitate. In complex with TLR6, promotes sterile inflammation in monocytes/macrophages in response to oxidized low-density lipoprotein (oxLDL) or amyloid-beta 42. In this context, the initial signal is provided by oxLDL- or amyloid-beta 42-binding to [...] | 0.496 |
| ADIPOR2 | ADIPOQ | ENSSSCP00000000805 | ENSSSCP00000046998 | Adiponectin receptor protein 2 isoform X1. | C1q domain-containing protein. | 0.999 |
| ADIPOR2 | INS | ENSSSCP00000000805 | ENSSSCP00000044635 | Adiponectin receptor protein 2 isoform X1. | Insulin A chain; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.659 |
| ADIPOR2 | LEP | ENSSSCP00000000805 | ENSSSCP00000056831 | Adiponectin receptor protein 2 isoform X1. | Leptin; Key player in the regulation of energy balance and body weight control. Once released into the circulation, has central and peripheral effects by binding LEPR, found in many tissues, which results in the activation of several major signaling pathways (By similarity). In the hypothalamus, acts as an appetite-regulating factor that induces a decrease in food intake and an increase in energy consumption by inducing anorexinogenic factors and suppressing orexigenic neuropeptides, also regulates bone mass and secretion of hypothalamo-pituitary-adrenal hormones. In the periphery, inc [...] | 0.801 |
| ADIPOR2 | NAMPT | ENSSSCP00000000805 | ENSSSCP00000043109 | Adiponectin receptor protein 2 isoform X1. | Nicotinamide phosphoribosyltransferase; Catalyzes the condensation of nicotinamide with 5- phosphoribosyl-1-pyrophosphate to yield nicotinamide mononucleotide, an intermediate in the biosynthesis of NAD. It is the rate limiting component in the mammalian NAD biosynthesis pathway. The secreted form behaves both as a cytokine with immunomodulating properties and an adipokine with anti-diabetic properties, it has no enzymatic activity, partly because of lack of activation by ATP, which has a low level in extracellular space and plasma. Plays a role in the modulation of circadian clock fun [...] | 0.678 |
| ADIPOR2 | RETNLB | ENSSSCP00000000805 | ENSSSCP00000012720 | Adiponectin receptor protein 2 isoform X1. | Resistin-like beta protein. | 0.712 |
| APLN | ADIPOQ | ENSSSCP00000071811 | ENSSSCP00000046998 | Apelin. | C1q domain-containing protein. | 0.565 |
| APLN | INS | ENSSSCP00000071811 | ENSSSCP00000044635 | Apelin. | Insulin A chain; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.640 |
| APLN | LEP | ENSSSCP00000071811 | ENSSSCP00000056831 | Apelin. | Leptin; Key player in the regulation of energy balance and body weight control. Once released into the circulation, has central and peripheral effects by binding LEPR, found in many tissues, which results in the activation of several major signaling pathways (By similarity). In the hypothalamus, acts as an appetite-regulating factor that induces a decrease in food intake and an increase in energy consumption by inducing anorexinogenic factors and suppressing orexigenic neuropeptides, also regulates bone mass and secretion of hypothalamo-pituitary-adrenal hormones. In the periphery, inc [...] | 0.546 |
| APLN | NAMPT | ENSSSCP00000071811 | ENSSSCP00000043109 | Apelin. | Nicotinamide phosphoribosyltransferase; Catalyzes the condensation of nicotinamide with 5- phosphoribosyl-1-pyrophosphate to yield nicotinamide mononucleotide, an intermediate in the biosynthesis of NAD. It is the rate limiting component in the mammalian NAD biosynthesis pathway. The secreted form behaves both as a cytokine with immunomodulating properties and an adipokine with anti-diabetic properties, it has no enzymatic activity, partly because of lack of activation by ATP, which has a low level in extracellular space and plasma. Plays a role in the modulation of circadian clock fun [...] | 0.602 |
| APLN | RETNLB | ENSSSCP00000071811 | ENSSSCP00000012720 | Apelin. | Resistin-like beta protein. | 0.629 |